Vitruvian Partners announces strategic growth investment in KCAS Bioanalytical and Biomarker Services
Vitruvian Partners announces strategic growth investment in KCAS Bioanalytical and Biomarker Services Vitruvian's acquisition enables KCAS to further accelerate global growth both through acquisitions and expansion of its U.S. operations Vitruvian Partners, one of the world's leading growth-focused investment firms, announced that it has acquired a majority ownership stake in KCAS Bioanalytical and Biomarker Services (KCAS), located in the Kansas City, Kansas metropolitan area. Both management and current majority shareholders KVCI are making a significant reinvestment in the company. Other ...